Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$4.78 USD
+0.05 (1.06%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $4.77 -0.01 (-0.21%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 7.69% |
ABR | 1.14 |
Earnings ESP
|
-6.15% |
---|---|
Current Year | -1.40 |
Next Year | -1.51 |
EPS (TTM) | -1.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.35 | -1.40 | -1.51 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | -0.37 | -0.37 | -1.46 | -1.55 |
High Estimate | -0.29 | -0.29 | -1.28 | -1.30 |
Low Estimate | -0.41 | -0.41 | -1.53 | -1.99 |
Year ago EPS | -0.45 | -0.34 | -1.88 | -1.40 |
Year over Year Growth Est. | 22.22% | -2.94% | 25.53% | -8.06% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 3 | 4 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.35 | -1.40 | -1.51 |
7 Days Ago | -0.35 | -0.35 | -1.40 | -1.51 |
30 Days Ago | -0.35 | -0.36 | -1.42 | -1.00 |
60 Days Ago | -0.37 | -0.37 | -1.47 | -1.00 |
90 Days Ago | -0.37 | -0.37 | -1.47 | -1.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.37 | -1.46 | -1.55 |
Zacks Consensus Estimate | -0.35 | -0.35 | -1.40 | -1.51 |
Earnings ESP | -6.15% | -7.25% | -4.39% | -2.55% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.35 | -0.34 | -0.45 | NA |
Estimate | -0.39 | -0.44 | -0.47 | -0.49 | NA |
Difference | 0.03 | 0.09 | 0.13 | 0.04 | 0.07 |
Surprise | 7.69% | 20.45% | 27.66% | 8.16% | 15.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more